Diabetes

Natural product-based Combinatorial therapy for TIIDM and Metabolic disease: A therapeutic mix encompassing a therapeutic mix encompassing Curcumin, Silymarin and Isorhapontigenin decreases blood glucose levels, stifles Hemoglobin A1c and fructosamine levels, brings down the levels of inflammatory mediators, augments insulin sensitivity, increases energy expenditure, promotes weight loss and alleviates TIIDM, metabolic disease and hepatic steatosis via up regulation of its target gene, 22/July/2017, 11.58 pm
Natural product-based Combinatorial therapy for TIIDM and Metabolic disease: A therapeutic mix encompassing a therapeutic mix encompassing Curcumin, Silymarin and Isorhapontigenin decreases blood glucose levels, stifles Hemoglobin A1c and fructosamine levels, brings down the levels of inflammatory mediators, augments insulin sensitivity, increases energy expenditure, promotes weight loss and alleviates TIIDM, metabolic disease and hepatic steatosis via up regulation of its target gene, 22/July/2017, 11.58 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA; Departments of Medicine and Pharmacology, University of California, San Diego School of Medicine, La…

read more

Natural product therapy for glucose homeostasis and TIIDM: Artesunate, isolated from Artemesia Annua L, increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 22/July/2017, 12.24 am
Natural product therapy for glucose homeostasis and TIIDM: Artesunate, isolated from Artemesia Annua L, increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 22/July/2017, 12.24 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel shows that “PAX6 maintains…

read more

Natural product-based Combinatorial therapy for TIIDM and Metabolic disease: A therapeutic mix encompassing Curcumin, Berberine and Epigallocatechin gallate decreases blood glucose levels, stifles Hemoglobin A1c and fructosamine levels, brings down the levels of inflammatory mediators, augments insulin sensitivity, increases energy expenditure, promotes weight loss and alleviates TIIDM, metabolic disease and hepatic steatosis via up regulation of its target gene, 20/July/2017, 12.01 am
Natural product-based Combinatorial therapy for TIIDM and Metabolic disease: A therapeutic mix encompassing Curcumin, Berberine and Epigallocatechin gallate decreases blood glucose levels, stifles Hemoglobin A1c and fructosamine levels, brings down the levels of inflammatory mediators, augments insulin sensitivity, increases energy expenditure, promotes weight loss and alleviates TIIDM, metabolic disease and hepatic steatosis via up regulation of its target gene, 20/July/2017, 12.01 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA; Departments of Medicine and Pharmacology, University of California, San Diego School of Medicine, La…

read more

Natural product-based Combinatorial therapy for TIIDM and Metabolic disease: A therapeutic mix encompassing Cholecalciferol, Oleanolic acid and Magnolol decreases blood glucose levels, stifles Hemoglobin A1c and fructosamine levels, brings down the levels of inflammatory mediators, augments insulin sensitivity, increases energy expenditure, promotes weight loss and alleviates TIIDM, metabolic disease and hepatic steatosis via up regulation of its target gene, 17/July/2017, 11.59 pm
Natural product-based Combinatorial therapy for TIIDM and Metabolic disease: A therapeutic mix encompassing Cholecalciferol, Oleanolic acid and Magnolol decreases blood glucose levels, stifles Hemoglobin A1c and fructosamine levels, brings down the levels of inflammatory mediators, augments insulin sensitivity, increases energy expenditure, promotes weight loss and alleviates TIIDM, metabolic disease and hepatic steatosis via up regulation of its target gene, 17/July/2017, 11.59 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA; Departments of Medicine and Pharmacology, University of California, San Diego School of…

read more

Natural product therapy for glucose homeostasis and TIIDM: β-Cryptoxanthin, isolated from Sweet peppers and Papaya, increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 17/July/2017, 12.23 am
Natural product therapy for glucose homeostasis and TIIDM: β-Cryptoxanthin, isolated from Sweet peppers and Papaya, increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 17/July/2017, 12.23 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel shows that “PAX6 maintains…

read more

Molecular therapy for Diabetic nephropathy (DN): Argonaute2 (Ago2) increases Pyruvate kinase M2 (PKM2) expression, decreases toxic glucose metabolites, mitochondrial dysfunction and apoptosis, augments glycolytic flux and PGC-1α levels, improves metabolic abnormalities, albuminuria, glomerular pathology, and renal dysfunction and alleviates diabetic nephropathy via down regulation of its target gene, 17/July/2017, 12.18 am
Molecular therapy for Diabetic nephropathy (DN): Argonaute2 (Ago2) increases Pyruvate kinase M2 (PKM2) expression, decreases toxic glucose metabolites, mitochondrial dysfunction and apoptosis, augments glycolytic flux and PGC-1α levels, improves metabolic abnormalities, albuminuria, glomerular pathology, and renal dysfunction and alleviates diabetic nephropathy via down regulation of its target gene, 17/July/2017, 12.18 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA shows that “Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular…

read more
Start Typing